<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mizikova I</submitter><funding>German Research Foundation</funding><funding>Frederick Banting and Charles Best Doctoral Scholarship</funding><funding>Finnish Foundation for Pediatric Research</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>Canadian Lung Association—Breathing</funding><funding>Molly Towel Perinatal Research Foundation Postdoctoral Fellowship</funding><funding>Finnish Sigrid Juselius Foundation</funding><funding>Canadian Institutes of Health Research</funding><funding>CIHR</funding><pagination>479-492</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9199848</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>40(5)</volume><pubmed_abstract>Late lung development is a period of alveolar and microvascular formation, which is pivotal in ensuring sufficient and effective gas exchange. Defects in late lung development manifest in premature infants as a chronic lung disease named bronchopulmonary dysplasia (BPD). Numerous studies demonstrated the therapeutic properties of exogenous bone marrow and umbilical cord-derived mesenchymal stromal cells (MSCs) in experimental BPD. However, very little is known regarding the regenerative capacity of resident lung MSCs (L-MSCs) during normal development and in BPD. In this study we aimed to characterize the L-MSC population in homeostasis and upon injury. We used single-cell RNA sequencing (scRNA-seq) to profile in situ Ly6a+ L-MSCs in the lungs of normal and O2-exposed neonatal mice (a well-established model to mimic BPD) at 3 developmental timepoints (postnatal days 3, 7, and 14). Hyperoxia exposure increased the number and altered the expression profile of L-MSCs, particularly by increasing the expression of multiple pro-inflammatory, pro-fibrotic, and anti-angiogenic genes. In order to identify potential changes induced in the L-MSCs transcriptome by storage and culture, we profiled 15 000 Ly6a+ L-MSCs after in vitro culture. We observed great differences in expression profiles of in situ and cultured L-MSCs, particularly those derived from healthy lungs. Additionally, we have identified the location of Ly6a+/Col14a1+ L-MSCs in the developing lung and propose Serpinf1 as a novel, culture-stable marker of L-MSCs. Finally, cell communication analysis suggests inflammatory signals from immune and endothelial cells as main drivers of hyperoxia-induced changes in L-MSCs transcriptome.</pubmed_abstract><journal>Stem cells (Dayton, Ohio)</journal><pubmed_title>Single-Cell RNA Sequencing-Based Characterization of Resident Lung Mesenchymal Stromal Cells in Bronchopulmonary Dysplasia.</pubmed_title><pmcid>PMC9199848</pmcid><funding_grant_id>#MI 2505_1-1</funding_grant_id><pubmed_authors>Mizikova I</pubmed_authors><pubmed_authors>Bardin P</pubmed_authors><pubmed_authors>Vanderhyden BC</pubmed_authors><pubmed_authors>Zhong S</pubmed_authors><pubmed_authors>Hanninen SM</pubmed_authors><pubmed_authors>Vadivel A</pubmed_authors><pubmed_authors>Lesage F</pubmed_authors><pubmed_authors>Carpen O</pubmed_authors><pubmed_authors>Cyr-Depauw C</pubmed_authors><pubmed_authors>Cook DP</pubmed_authors><pubmed_authors>Hurskainen M</pubmed_authors><pubmed_authors>Thebaud B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Single-Cell RNA Sequencing-Based Characterization of Resident Lung Mesenchymal Stromal Cells in Bronchopulmonary Dysplasia.</name><description>Late lung development is a period of alveolar and microvascular formation, which is pivotal in ensuring sufficient and effective gas exchange. Defects in late lung development manifest in premature infants as a chronic lung disease named bronchopulmonary dysplasia (BPD). Numerous studies demonstrated the therapeutic properties of exogenous bone marrow and umbilical cord-derived mesenchymal stromal cells (MSCs) in experimental BPD. However, very little is known regarding the regenerative capacity of resident lung MSCs (L-MSCs) during normal development and in BPD. In this study we aimed to characterize the L-MSC population in homeostasis and upon injury. We used single-cell RNA sequencing (scRNA-seq) to profile in situ Ly6a+ L-MSCs in the lungs of normal and O2-exposed neonatal mice (a well-established model to mimic BPD) at 3 developmental timepoints (postnatal days 3, 7, and 14). Hyperoxia exposure increased the number and altered the expression profile of L-MSCs, particularly by increasing the expression of multiple pro-inflammatory, pro-fibrotic, and anti-angiogenic genes. In order to identify potential changes induced in the L-MSCs transcriptome by storage and culture, we profiled 15 000 Ly6a+ L-MSCs after in vitro culture. We observed great differences in expression profiles of in situ and cultured L-MSCs, particularly those derived from healthy lungs. Additionally, we have identified the location of Ly6a+/Col14a1+ L-MSCs in the developing lung and propose Serpinf1 as a novel, culture-stable marker of L-MSCs. Finally, cell communication analysis suggests inflammatory signals from immune and endothelial cells as main drivers of hyperoxia-induced changes in L-MSCs transcriptome.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-22T11:56:26.043Z</modification><creation>2025-04-06T00:10:00.628Z</creation></dates><accession>S-EPMC9199848</accession><cross_references><pubmed>35445270</pubmed><doi>10.1093/stmcls/sxab023</doi></cross_references></HashMap>